Status:
RECRUITING
Telemonitoring of Hypertensive Patients With Chronic Kidney Disease
Lead Sponsor:
University of Alberta
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Hypertension, together with poorly controlled blood pressure (BP) are known risk factors for kidney disease and progression to kidney failure as well as increased cardiovascular (CV) morb...
Detailed Description
Introduction: Poorly controlled blood pressure (BP) is a risk factor for rapid progression of chronic kidney disease (CKD) to kidney failure and is also associated with cardiovascular (CV) morbidity ...
Eligibility Criteria
Inclusion
- Age equal to and more than 18 years with documented diagnosis of established CKD (not on dialysis with eGFR \< 60 mL/min/1.73m2 and/or proteinuria \> 1 g/day)
- Remote dwelling patients in the Peace River region of Alberta, Canada
- Patients known with hypertension (physician diagnosed / self reported and currently taking antihypertensive medications)
- Owning a smartphone (iOS or Android) with access to wireless internet connection.
- Proficiency in English language (both verbal and written); and ability and willingness to provide informed consent for participation.
- Ability and willingness to use the HBPT device (≥ 80% recordings sent in the training period)
Exclusion
- Patients with hypertensive urgency or emergency identified during the training period (immediate consultation will be initiated with the patient's PCP or with a hypertension specialist)
- Patients with stage 5 CKD (eGFR ≤ 15 ml/min/1.73m2) or patients receiving kidney replacement therapy
- Heart failure with reduced ejection fraction
- Presence of any terminal illness (life expectancy \< 1 year)
- Participation in any ongoing clinical drug trial
- Pregnancy, lactation / breastfeeding
- Planning to relocate out of the Peace River region or residence in an area without mobile phone coverage.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT04098354
Start Date
April 15 2022
End Date
December 31 2026
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Albert, Canada, T6G 2C8